| ID | CAS | Name | Synonyms | Description |
|---|---|---|---|---|
| 1 | 114977-28-5 | Taxotere | TAXOTERE Taxotere docetaxel Docetaxel Decetaxel Taxotere anhydrous Docetaxel Anhydrous Decetaxel anhydrous n-debenzoyl-n-tert-butoxycarbonyl-10-deacetyl taxol N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol Docetaxel N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol )benz(1,2-b)oxet-9-ylester,(2ar-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alph (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate (1beta,2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)- Benzenepropanoic acid, b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trih ydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (aR,bS)- | Taxotere;Intermediates;Active Pharmac;Pharmaceutical intermediates;Pharmaceutical material and intermeidates |
| 2 | 125-84-8 | aminoglutethimide | aminoglutethimide Aminoglutethimide TIMTEC-BB SBB000711 DL-Aminoglutethimide Aminoglutethimide(Ag) 2-(p-Aminophenyl)-2-ethylglutarimide 2-(4-aminophenyl)-2-ethylglutarimide 2-(p-aminophenyl)-2-ethyl-glutarimid 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione 2-(p-Aminophenyl)-2-ethylglutarimide2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl- | CYTADREN;Inhibitors;Biochemistry;Raw materials;Pharmaceuticals;Reference substance;Medical raw materials;Small molecule inhibitors;Antitumors for Research and;Pharmaceutical raw materials |
| 3 | 125317-39-7 | Vinorelbine Ditartrate | Nvb Navelbine Vinorelbin Bitartrate Pacilitaxel Navelbine tartrate Vinorelbine tartrate Vinorelbine tartarate Vinorelbine bitratrate Vinorelbine Ditartrate Vinorelbine bitartrate VinorelbineTartrateUsp28 VINORELBINE TARTRATE, USP Vinorelbine ditartrate salt Vinorelbine ditartaric acid VINORELBINE TARTRATE, NAVELBINE VINORELBINE TARTRATE USP STANDARD Vinorelbine tartrate usp standard Vinorelbineditartrate salt hydrate 5'-noranhydrovinoblastine tartrate VINORELBINEDITARTRATE SALT HYDRATE 3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine VINORELBINE RELATED COMPOUND A4-O-DEACETYLVINORELBINE TARTRATE USP STANDARD C'-norvincaleukoblastine,3',4'-didehydro-4'-dioxy-,(R-(R*,R*))-2,3-dihydroxy (3Ar,3A1R,4R,5S,5Ar,10Br)-Methyl 4-Acetoxy-3A-Ethyl-9-((2S,6S,8S)-4-Ethyl-8-(Methoxycarbonyl)-1,3,6,7,8,9-Hexahydro-2,6-Methanoazecino[4,3-B]Indol-8-Yl)-5-Hydroxy-8-Methoxy-6-Methyl-3A,3A1,4,5,5A,6,11 methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate | APIs;VINORELBIN;analytical reagent;antineoplastic drugs;cell biology reagents;Pharmaceutical raw materials;pharmaceutical raw materials;cell signaling and neurobiology;TABINES anti-cancer products (An |
| 4 | 150399-23-8 | Pemetrexed disodium | PEMETREXED SODIUM Premetred disodium Pemetrexed Disodium PEMETREXED DISODIUM Pemetrexed disodium PEMETREXED DISODIUM 2.5H2O PEMETREXED DISODIUM(ALIMTA) PEMETREXED DISODIUM FOR INJECTION PEMETREXED DISODIUM FOR INJECTION BK-A-01 N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-D-glutamic acid n-[4-[2-(2-amino-4,7-dihydro-4-oxo-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid disodium salt 2-[4-[2-(4-Amino-2-oxo-3,5,7-triazabicyclo[4.3.0]nona-3,8,10-trien-9-yl)ethyl]benzoyl]aminopentanedioic acid disodium salt | Inhibit;All Inhibitors;Organic materials;Organometallic compounds;Molecular Targeted Antineoplastic |
| 5 | 189453-10-9 | Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl-, (4S,7R,8S,9S,13Z,16S)- | 12 CS-1161 KOS 862 Epothilone D Desoxyepothilone B DESOXYEPOTHILONE B 13-DESOXYEPOTHILONE B 13-Desoxyepothilone B (4S,7R,8S,9S,13Z)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]oxacyclohexadec-13-ene-2,6-dione (3S,7S,14S,15S,16R)-3,15-Dihydroxy-2,2,10,14,16-pentamethyl-7-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-6-oxacyclohexadec-9-ene-1,5-dione (4R,7S,8S,9S,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]oxacyclohexadec-13-ene-2,6-dione Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl-, (4S,7R,8S,9S,13Z,16S)- Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl -16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (4S-(4R*,7S,8R*,9R*,1 3Z,16R*(E)))- | Raw drugs;Inhibitors;Raw materials;Intermediates;Chiral Reagents;Pharmaceuticals;Anti-cancer&immunity;Medical raw materials;Pharmaceutical bulk drugs;Sulfur & Selenium Compounds |
| 6 | 212141-54-3 | Vatalanib base | Pynasunate Vatalanib base PTK787 free base Vatalanib free base (PTK787 free base Vatalanib (PTK787) Dihydrochloride Base Pynasunate, ZK222584, CGP-79787, PTK 787 N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)- 1-Phthalazinamine 1-PhthalazinaMine, N-(4-chlorophenyl)-4-(4-pyridinylMethyl)- (4-Chloro-phenyl)-(4-pyridin-4-ylmethyl-phthalazin-1-yl)-amine | Antineoplastic |
| 7 | 2468-21-5 | Catharanthine | 18-beta)-lph catharanthin Catharanthine (+)-CATHRANTHINE 4-Didehydrocoronaridine (+)-3,4-didehydrocoronaridine methyl (5beta)-3,4-didehydroibogamine-18-carboxylate methyl (5beta,18beta)-3,4-didehydroibogamine-18-carboxylate methyl (2alpha,5beta,18beta)-3,4-didehydroibogamine-18-carboxylate ibogamine-18-carboxylicacid,3,4-didehydro-,methylester,(2-alpha,5-beta,6-a methyl(2-alpha,5-beta,6-alpha,18-beta)-3,4-didehydroibogamine-18-carboxylate | ;phytochemical;chemical reagent;Plant extraction;Standard substance;standardized herbal ex;pharmaceutical intermediate;Reference substance, standard substance;Traditional Chinese medicine reference su |
| 8 | 288383-20-0 | Cediranib | AZD2171 Recentin Cediranib Cadiranib Cediranib R Cediranib(AZD2171) Cadiranib (AZD2171) 4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline | API;APIs;Protei;Inhibitors;Antineoplastic;Anti-tumor drugs;Cell biology reagents;Scientific research reagents;Pharmaceutical intermediates;Anti-tumor drugs and immunosuppressants |
| 9 | 33069-62-4 | Paclitaxel | taxal taxol a PACLITAXEL Paclitaxel PACLITAXOL Paclitaxelx Paclitaxel HCL PACLITAXEL, TAXUS SPECIES Paclitaxel(natural crude) PACLITAXEL, TAXUS BREVIFOLIA N-BENZYL-BETA-PHENYLISOSERINE ESTER 7,11-methano-5h-cyclodeca[3,4]benz[1,2-b]oxete benzenepropanoic acid deriv. | Intermediates;Plant extracts;chemical reagent;pharmaceutical int;Pharmaceutical intermediates |
| 10 | 3543-75-7 | Bendamustine Hydrochloride | Treanda CYTOSTASAN Bendamustine CytostasanHCl BENDAMUSTINE HCL Phenol,5-iodo-7-methyl- BENDAMUSTIN HYDROCHLORIDE Bendamustine Hydrochloride 1-methyl-5-bis(2-chloroethyl)amino-2-benzimidazolinebutryricacihydrochlor gamma(1-methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydro 1-methyl-5-bis(2-chloroethyl)amino-2-benzimidazolinebutryric acid hydrochloride 4-[5-[Bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butyric acid hydrochloride 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid hydrochloride | API;Inorganic salt;Inorganic Chemical Engineering |
| 11 | 38390-45-3 | 3',4'-Anhydrovinblastine | C11641 F 81097 ANHYDROVINBLASTINE Anhydrovinblastine Vinblastineanhydrous 3',4'-Dehydrovinblastine 3',4'-Anhydrovinblastine 3',4'-anhydrovinblastine Anhydrovincaleukoblastine 3',4'-Dehydroisoleurosine 3',4'-Didehydrovinblastine 3',4'-Didehydroisoleurosine 3',4'-Didehydro-4'-deoxyvincaleukoblastine 3',4'-Didehydro-4'-deoxuvincaleukoblastine Vincaleukoblastine, 3',4'-didehydro-4'-deoxy- methyl (2beta,3beta,4beta,5alpha,19alpha)-4-(acetyloxy)-15-[(7R,9S)-5-ethyl-9-(methoxycarbonyl)-1,4,7,8,9,10-hexahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-9-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(7S,9S)-5-ethyl-9-(methoxycarbonyl)-1,4,7,8,9,10-hexahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-9-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate | ;phytochemical;Plant extract;chemical reagent;Standard substance;Reference substance;Small molecule inhibitor;Extract standard substance;pharmaceutical intermediate;standardized herbal extract |
| 12 | 404844-02-6 | N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}-4-(piperazin-1-ylmethyl)benzamide | CGP-74588 STI 509-00 Norimatinib N-Desmethyl gleevec N-Desmethyl Imatinib IMATINIB METABOLITE N-DESMETHYL IMATINIB (N-DESMETHYL IMATINIB) N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}-4-(piperazin-1-ylmethyl)benzamide N-{4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}-4-(piperazin-1-ylmethyl)benzamide N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)-benzamide Benzamide,N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)- | Isotopi;Impurities;Metabolites;Acyl halide;Pharmaceuticals;Imatinib impurity f;Raw drug impurities;Various Metabolites a;Intermediate impurities;Pharmaceutical impurities |
| 13 | 41575-94-4 | 1,1-Cyclobutanedicarboxylatodiammineplatinum (II) | CBDCA ammonia PARAPLATIN Paraplatin Carboplatin CARBOPLATIN CARBOPLATINUM 1,1-Cyclobutanedicarboxylatodiammineplatinum 1,1-cyclobutanedicarboxylatediammineplatinum(ii) diammine(1,1-cyclobutanedicarboxylato)-platinum(I CIS-DIAMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM 1,1-Cyclobutanedicarboxylatodiammineplatinum (II) 1,1-Cyclobutanedicarboxylate diamine platinum(II) DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II) 1-cyclobutanedicarboxylato)diammine-(cis-platinum(ii cis-(1,1-Cyclobutanedicarboxylato)diamineplatinum(II) cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II) 1-cyclobutanedicarboxylato(2-)-o,o')-diammine((sp-4-2)-platinu Platinum, diamine(1,1-cyclobutanedicarboxylato(2-)-O,O')-,(SP-4-2)- diamino[cyclobutane-1,1-dicarboxylato(2-)-kappa~2~O~1~,O~1~]platinum | drugs;Active P;intermediates;raw materials;Anti-tumor drugs;general reagents;other anti-tumor drugs;platinum-containing catalysts;catalysis and inorganic chemistry;anti-tumor drugs and immunosuppressa |
| 14 | 479-41-4 | Indirubin | Indirubin Nsc105327 C.I. 73200 INDIRUBIN (RG) 2,3'-biindole-2',3(1H,1'H)-dione [2,3'-Biindolinylidene]-2',3-dione (2Z)-2,3'-biindole-2',3(1H,1'H)-dione 2-(2-oxo-1h-indol-3-ylidene)-1h-indol-3-one (E)-3-(3-oxoindolin-2-ylidene)indolin-2-one 3-(1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,3-dihydro- 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro- | Natur;Dyes and pigments;Active Pharmaceutical Ingredients |
| 15 | 50-07-7 | Mitomycin | Mitomycin Mitomycin C Mitomycin C, Streptomyces caespitosus mitomycin C from streptomyces*caespitosus | Antibiotics;Antibiotic Explorer;Intermediates & Fine Chemicals |
| 16 | 501-36-0 | resveratrol | RESVERATROL Resveratrol resveratrol RESVERATROLE TRANS-RESVERATROL Veratrum album L alcohol TRANS-3,5,4'-STILBENETRIOL TRANS-3,4,5-TRIHYDROXYSTILBENE trans-3,4,5-Trihydroxystilbene 3,4',5-Trihydroxy-trans-stilbene 3,4',5-TRIHYDROXY-TRANS-STILBENE 3,4',5'-TRIHYDROXY-TRANS-STILBENE TRANS-1,2-(3,4',5-TRIHYDROXYDIPHENYL)ETHYLENE 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol | ;Biological medicine;Chinese herbal medicine extract |
| 17 | 5072-26-4 | DL-BUTHIONINE-[S,R]-SULFOXIMINE | buthioninesulfoxamine buthioninesulfoximine DL-BUTHIONINE-SULFOXIMINE DL-BUTHIONINE (S,R)-SULPHOXIME DL-BUTHIONINE-[S,R]-SULFOXIMINE DL-BUTHIONINE (R,S)-SULFOXIMINE 2-amino-4-(s-butylsulfonimidoyl)butanoicacid 2-amino-4-(s-butylsulfonimidoyl)-butanoicaci (2R)-2-amino-4-(S-butylsulfonimidoyl)butanoic acid | D to;Organic acids;Organic materials;Sulfur & Selenium Compounds;Enzyme Inhibitors by Enzyme;Glutathione S-Transferase Agents;Drug and Xenobiotic Metabolism;Fusarinine -C OrnithinesteraseMult |
| 18 | 694499-26-8 | Benzenamine, 4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)- | 4-(4-Methylpiperazinomethyl)-3-(trifluoromethyl)aniline 4-(4-Methylpiperazinomethyl)-3-(trifluoromethyl)aniline 4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline 4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)aniline 4-((4-Methylpiperazin-1-yl)methyl)-3-trifluoromethylphenylamine 4-[(4-Methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)benzenamine BenzenaMine, 4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)- Benzenamine, 4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)- 5-Amino-2-[(4-methylpiperazin-1-yl)methyl]benzotrifluoride, 1-[4-Amino-2-(trifluoromethyl)benzyl]-4-methylpiperazine | Organic fluoride;Organic raw materials |
| 19 | 698387-09-6 | Neratinib | HKI-272 HKI272 HKI 272 Neratinib neratinib Unii-jjh94R3pwb Neratinib(HKI-272) N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide (E)-N-[4-[3-Chloro-4-[(2-pyridinyl)methoxy]anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide (2E)-N-[4-[[3-chloro-4-(2-pyridinylMethoxy)phenyl]aMino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(diMethylaMino)-2-butenaMide (2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide (2e)-n-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide | Inhibitors;Antineoplas;Intermediates;Anti-cancer & immunity;Pharmaceutical intermediates |
| 20 | 54117-37-2 | 9-BENZYL-3-FORMYLCARBAZOLE | 9-BENZYL-3-FORMYLCARBAZOLE 9-Benzylcarbazole-3-carbaldehyde 9-Benzyl-3-carbazolecarboxaldehyde 9-BENZYLCARBAZOLE-3-CARBOXALDEHYDE 9-benzyl-9H-carbazole-3-carbaldehyde 9-Benzyl-9H-carbazole-3-carboxaldehyde 9-(Phenylmethyl)-9H-carbazole-3-carboxaldehyde | ;Aldehydes;Carbazoles;General Reagents;Functional Materials;Organic building blocks;Reagents for Conducting Polymer Research;Imidazole, pyrazole and other derivatives;Carbazoles (for Conduting Polymer |
| 21 | 120210-48-2 | TENIDAP | TENIDAP AKOS 91367 5-Chloro-2,3-dihydro-2-oxo-3-(2-thenoyl)-1H-indole-1-carboxamide (3Z)-5-Chloro-2,3-dihydro-3-(hydroxy-2-thienylMethylene)-2-oxo-1H-indole-1-carboxaMide (Z)-5-Chloro-2,3-dihydro-3-(hydroxy-2-thienylMethylene)-2-oxo-1H- indole-1-carboxaMide 1H-Indole-1-carboxamide, 5-chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-, (3Z)- | Drugs;Central nervous system drugs;Non-steroidal anti-inflammatory drugs |
| 22 | 656247-17-5 | Nintedanib | 100837 BIBF 1120 VARGATEF INTEDANIB Nintedanib Nintedanib-016 INTEDANIB BASE Intedanib Vargatef Intedanib Vargatef Nintedanib (BIBF 1120) | API;Amines;Inhibitors;Nintedanib;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 23 | 1194506-26-7 | Fruquintinib | CS-1643 R-228060 HMPL-013 Fruquintinib 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide 6-[(6,7-Dimethoxy-4-quinazolinyl)oxy]-N,2-dimethyl-3-benzofurancarboxamide 3-Benzofurancarboxamide, 6-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N,2-dimethyl- | Inhibitors |
| 24 | 1108743-60-7 | Entrectinib | RXDX-101 Entrectinib entrecitinib NVP-LGK974, WNT974 Entrectinib(NMS-E628) N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]benzamide | Intermediates-Pharmaceutical Intermediates |
| 25 | 63612-50-0 | Nilutamide | Nilutamide Nilandrone RU 23908-10 1-3-Trifluoromethyl-4-nitrophenyl)-4,4-dimethylimidazoline-2,5-dione 5,5-Dimethyl-3-[4-nitrcr3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione 3-(3-(trifluoromethyl)-4-nitrophenyl)-5,5-dimethylimidazolidine-2,4-dione | Aromatics Compounds;Molecular Targeted Antineoplastic |
| 26 | 58994-96-0 | Ranimustine | MCNU Cymerin Thymerin NSC-0270516 Ranomustine Ranimustine Methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-α-D-glucopyranoside Methyl 6-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside 1-(2-chloroethyl)-1-nitroso-3-[[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-methoxy-oxan-2-yl]methyl]urea | antineoplastic drugs |
| 27 | 24316-19-6 | Cephalotaxlen | NSC 128487 NSC 245454 Cephalotaxin CEPHALOTAXINE ZINC19795976) Cephalotaxlen Cephalotaxlen ((-)-Cephalotaxine [1S-(1a,3aS*,14b)]-1,5,6,8,9,14b-Hexahydro-2-methoxy-4H-cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-ol | Alkaloids;Heterocycles;Plant extract;Chiral Reagents;Pharmaceuticals;Standard substance;Reference substance;Extract standard substance;Analysis of reference subst;Intermediates & Fine Chemicals |
| 28 | 117091-64-2 | Etoposide Phosphate | ETOPOPHOS ETOPOSIDE PHOSPHATE Etoposide Phosphate Etoposide phosphate ETOPOSIDE PHOSPHONATE Etoposide 4'-Phosphate ETOPOSIDE PHOSPHONATE, ETOPOPHOS BMY-40481, Etoposide 4'-Dihydrogenphosphate | API;Inhibitors;Heterocycles;Antineoplastic;Drug Analogues;Pharmaceuticals;Carbohydrates & Derivatives;Intermediates & Fine Chemicals;Signal transduction pathway kinase inhibitor |
| 29 | 102676-47-1 | FADROZOLE | Afema FADROZOLE CGS-16949 Fadrozole Hydrochloride Hydrate 5,6,7,8-Tetrahydro-5-(4-cyanophenyl)imidazo[1,5-a]pyridine 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridine-5-yl)benzonitrile 4-[[5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin]-5-yl]benzonitrile 4-[(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin)-5-yl]benzonitrile | drug;antineoplastic drugs;cell biology reagents;other antineoplastic drugs |
| 30 | 205923-56-4 | CETUXIMAB | IMC 225 Hsdb 7454 CETUXIMAB EGFR antibody CetuxiMab(C225) Cetuximab - Buffer solution | Cell biology reagent |
| 31 | 86696-86-8 | Piperazinone, 3-(2-thienyl)- (9CI) | Tenilsetam 3-(2-thienyl)- (9CI) 3-(2-Thienyl)piperazin-2-one 3-(2-Thienyl)-2-piperazinone 2-Piperazinone, 3-(2-thienyl)- Piperazinone, 3-(2-thienyl)- (9CI) | PIPERIDINE;pharmacetical;Pharmaceutical raw materials |
| 32 | 1537032-82-8 | Avelumab | Avelumab Avelumab (anti- PD-L1) Avelumab (MSB0010718C) | |
| 33 | 946414-94-4 | Nivolumab | Opdivo ONO 4538 MDX 1106 Nivolumab BMS 936558 Nivolumab (anti-PD-1) | Cell biology reagents |
| 34 | 174722-31-7 | Rituximab | Rituxan Mabthera Rituximab Hsdb 7455 Mab thera Immunoglobulin G1 Ig gamma-1 chain C region IMMunoglobulin G1,anti-(huMan CD20 (antigen)) (huMan-Mouse Monoclonal IDEC-C2B8 g1-chain), disulfide withhuMan-Mouse Monoclonal IDEC-C2B8 k-chain, diMer Immunoglobulin G 1 (human-mouse monoclonal idec-C2B8 gamma1-chain anti-human antigen cd 20), disulfide with human-mouse monoclonal idec-C2B8 kappa-chain, dimer | API;Chemical reagents;API and intermediates;Monoclonal antibody 18;Biochemical reagents-protein |
| 35 | 156436-89-4 | motexafin gadolinium | motexafin gadolinium motexafin gadolinium hydrate Xcytrin, PCI-0120, gadolinium texaphyrin, Gd texaphyrin, Gd-Tex, FP-GP1, API-GP3 | Antineoplastic agents |
| 36 | 1393344-72-3 | varlilumab | varlilumab | |
| 37 | 934823-49-1 | Urelumab | Urelumab | |
| 38 | 1655504-04-3 | Orelabrutinib | ICP-022 Orelabrutinib 3-Pyridinecarboxamide, 6-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)- | Raw material;Chemical reagent;Reference substance;Chemical engineering;Pharmaceutical raw material |
| 39 | 780758-10-3 | Nimotuzumab | Nimotuzumab | |
| 40 | 1143503-69-8 | Ixekizumab | Ixekizumab | Pharmaceutically active molecule |
| 41 | 1801338-64-6 | Odronextamab | Odronextamab | |
| 42 | 2137049-37-5 | Ieramilimab | Ieramilimab | |
| 43 | 1496553-00-4 | Zolbetuximab | Zolbetuximab | |
| 44 | 1858168-59-8 | Tislelizumab | Tislelizumab | |
| 45 | 1584645-37-3 | Rozanolixizumab | Rozanolixizumab | |
| 46 | 1613313-01-1 | Rovalpituzumab | Rovalpituzumab | |
| 47 | 1924598-82-2 | Toripalimab | Toripalimab | |
| 48 | 2050232-20-5 | Belantamab Mafodotin | Belantamab Mafodotin | Antibody |
| 49 | 1918185-84-8 | Tiragolumab | Tiragolumab | |
| 50 | 1905409-39-3 | Mosunetuzumab | Mosunetuzumab | |
| 51 | 1296818-77-3 | Nesvacumab | Nesvacumab | |
| 52 | 1236278-28-6 | Clazakizumab | Clazakizumab | |
| 53 | 2101242-53-7 | Cibisatamab | Cibisatamab | |
| 54 | 1622140-49-1 | Selicrelumab | Selicrelumab | |
| 55 | 1350624-75-7 | Margetuximab | Margetuximab | |
| 56 | 1952272-74-0 | Bemarituzumab | Bemarituzumab | |
| 57 | 915296-00-3 | Elotuzumab | Elotuzumab | |
| 58 | 1346452-25-2 | Enfortumab Vedotin | Enfortumab Vedotin | |
| 59 | 1318075-13-6 | Simtuzumab | Simtuzumab | |
| 60 | 915810-67-2 | Caplacizumab | Caplacizumab | |
| 61 | 1020748-57-5 | Moxetumomab Pasudotox | LUMOXITI Moxetumomab Pasudotox | |
| 62 | 916138-87-9 | Girentuximab | Girentuximab | |
| 63 | 1399546-01-0 | Cusatuzumab | Cusatuzumab | |
| 64 | 1582205-90-0 | Erenumab | Erenumab | |
| 65 | 948564-73-6 | Fresolimumab | Fresolimumab | |
| 66 | 2072873-06-2 | Sintilimab | Sintilimab | |
| 67 | 1461640-62-9 | Isatuximab | Isatuximab | |
| 68 | 1365267-33-9 | Codrituzumab | Codrituzumab | |
| 69 | 2169232-81-7 | Magrolimab | Magrolimab | |
| 70 | 2049079-64-1 | Sutimlimab | Sutimlimab | |
| 71 | 1313206-42-6 | Polatuzumab vedotin | Polatuzumab vedotin | |
| 72 | 62473-79-4 | Teniloxazine | Teniloxazine Unii-95Q6wnp25p Teniloxazine [inn] Morpholine, 2-[[2-(2-thienylmethyl)phenoxy]methyl]- | Pharmaceutical raw materials |
| 73 | 85136-71-6 | Tilisolol | Tilisolol 4-[3-(tert-butylamino)-2-hydroxypropoxy]-2-methylisoquinolin-1-one 4-(3-tert-Butylamino-2-hydroxypropoxy)-2-methylisoquinoline-1(2H)-one (+-)-4-(3-tert-Butylamino-2-hydroxypropoxy)-2-methyl-1(2H)-isoquinolinone 4-(3-tert-Butylamino-2-hydroxypropoxy)-2-methyl-1,2-dihydroisoquinoline-1-one 1(2H)-Isoquinolinone, 4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-2-methyl- 4-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropyloxy]-2-methylisoquinolin-1(2H)-one 1(2H)-Isoquinolinone, 4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-2-methyl- (9CI) | Pharmaceutical raw materials |